For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
1
views
0
references
 Top references
cited by
10
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      The predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This study was undertaken to determine whether levels of inflammation and endothelial dysfunction biomarkers in serum samples collected at baseline in the Diabetes Control and Complications Trial (DCCT) cohort could predict the development of retinopathy.

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): J. Diabetes Complicat.
          Title: Journal of diabetes and its complications
          ISSN (Electronic): 1873-460X
          ISSN (Print): 1056-8727
          Publication date (Electronic):
          Volume: 29
          Issue: 1
          Affiliations
          [1 ] Department of Medicine, Division of Endocrinology, Diabetes and Medical Genetics, Medical University of South Carolina, Charleston, SC, USA.
          [2 ] Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
          [3 ] Department of Medicine, Division of Endocrinology, Diabetes and Medical Genetics, Medical University of South Carolina, Charleston, SC, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
          [4 ] The Biostatistics Center, George Washington University, Washington DC, Washington DC, USA.
          [5 ] Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
          [6 ] Department of Medicine, Division of Endocrinology, Diabetes and Medical Genetics, Medical University of South Carolina, Charleston, SC, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA. Electronic address: virellam@musc.edu.
          Article
          Publisher Item ID: S1056-8727(14)00250-5 Mid ID: NIHMS640887
          DOI: 10.1016/j.jdiacomp.2014.08.004
          PMC ID: 4426877
          PubMed ID: 25441222
          SO-VID: cb82953a-9747-4d73-b9a3-f7f99117c438
          Copyright © Published by Elsevier Inc.
          History

          Keywords: Biomarkers,Diabetes complications,E-selectin,Plasminogen activator inhibitor type 1,Retinopathy,Type 1 diabetes
          Data availability:
          Keywords: Biomarkers, Diabetes complications, E-selectin, Plasminogen activator inhibitor type 1, Retinopathy, Type 1 diabetes

          Comments

          Comment on this article